BioNTech SE
BNTX
$89.27
-$0.04-0.05%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -40.52% | 499.94% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -40.52% | 499.94% | |||
| Cost of Revenue | 103.30% | 99.96% | |||
| Gross Profit | -56.08% | 665.66% | |||
| SG&A Expenses | 46.10% | 11.33% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -73.47% | 2,899.57% | |||
| Total Operating Expenses | -22.37% | 129.20% | |||
| Operating Income | -813.04% | 92.22% | |||
| Income Before Tax | -1,016.70% | 106.32% | |||
| Income Tax Expenses | 44.69% | 441.67% | |||
| Earnings from Continuing Operations | -958.16% | 92.35% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -958.16% | 92.35% | |||
| EBIT | -813.04% | 92.22% | |||
| EBITDA | -391.45% | 124.36% | |||
| EPS Basic | -936.28% | 92.27% | |||
| Normalized Basic EPS | -594.93% | 111.16% | |||
| EPS Diluted | -936.28% | 92.27% | |||
| Normalized Diluted EPS | -594.93% | 111.16% | |||
| Average Basic Shares Outstanding | 2.10% | -1.02% | |||
| Average Diluted Shares Outstanding | 2.10% | -1.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||